![]() IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. | ||
Founding Date | Founding Date 2014 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations Gaithersburg, US HQ |
Employees | Employees 19 | Employees 78 |
Valuation ($) | Valuation ($) 85.3 m | Valuation ($) 4.7 b |
Financial | ||
Net income | Net income ($95.5m) (FY, 2024) | Net income ($228.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 165.9m | Total funding raised $ 200m |

Arcellx is a clinical-stage biotechnology company developing adaptive immune cell therapies.
View company